SEC CIK 1504780

Furber Jeffrey D.

Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
STAGview stock →56,1332026-10-15

Position History — STAG

Reported shares owned immediately after each Form 4 transaction, over time.

018,71137,42256,1332011-042013-042015-052017-042020-012023-012025-102026-10

Recent Filings — STAG

DateActivitySharesPriceOwned After
2026-10-15Grant / award589$36.0356,133
2026-07-15Grant / award546$38.8955,544
2026-04-15Grant / award576$36.8654,998
2026-01-15Grant / award568$37.3654,422
2026-01-08Grant / award (derivative)3,369—58,945
2025-10-15Grant / award591$35.9353,854
2025-07-15Grant / award585$36.3153,263
2025-04-15Grant / award632$33.6052,678
2025-01-15Grant / award632$33.5852,046
2025-01-07Grant / award (derivative)3,812—55,576
2024-10-15Grant / award556$38.1951,414
2024-07-15Grant / award594$35.7550,858
2024-04-15Grant / award563$37.7150,264
2024-01-16Grant / award448$39.0149,701
2024-01-08Grant / award (derivative)3,243—51,764
2023-10-16Grant / award509$34.3349,253
2023-07-17Grant / award482$36.2648,744
2023-04-17Grant / award528$33.1348,262
2023-01-17Grant / award528$33.1047,734
2023-01-11Grant / award (derivative)3,299—48,521
2022-10-17Grant / award621$28.1446,805
2022-07-15Grant / award565$30.9446,184
2022-04-18Grant / award423$41.2845,619
2022-01-18Grant / award355$45.7245,196
2022-01-10Grant / award (derivative)2,615—45,222
2021-07-15Grant / award425$38.1644,841
2021-04-15Grant / award471$34.4744,416
2021-01-15Grant / award532$30.5243,945
2021-01-07Grant / award (derivative)3,555—42,607
2020-10-15Grant / award510$31.8643,413
2020-07-15Grant / award555$29.2542,903
2020-04-15Grant / award697$23.3042,348
2020-01-15Grant / award476$31.4641,651
2020-01-08Grant / award (derivative)3,393—39,052
2019-10-15Grant / award502$29.8441,175
2019-07-15Grant / award492$30.4840,673
2019-04-15Grant / award507$29.5340,181
2019-01-15Grant / award602$24.8839,674
2019-01-07Grant / award (derivative)3,828—35,659
2018-10-15Grant / award560$26.7639,072
2018-07-16Grant / award547$27.4038,512
2018-04-16Grant / award631$23.7437,965
2018-01-16Grant / award560$26.7846,114
2018-01-05Grant / award (derivative)3,592—31,831
2017-10-16Grant / award537$27.8945,554
2017-07-17Grant / award551$27.2045,017
2017-04-17Grant / award590$25.4044,466
2017-01-17Grant / award629$23.8443,876
2017-01-06Grant / award (derivative)2,806—28,239
2016-11-02Disposition to issuer4,000$25.000
2016-10-17Grant / award649$23.1143,247
2016-07-15Grant / award629$23.8342,598
2016-04-15Grant / award750$20.0041,969
2016-01-15Grant / award817$18.3541,219
2016-01-06Grant / award (derivative)3,744—25,433
2015-10-15Grant / award793$18.9140,402
2015-07-15Grant / award733$20.4439,609
2015-05-13Open-market buy1,000$21.4538,876
2015-05-13Open-market buy3,000$21.4637,876
2015-05-13Open-market buy1,000$21.4734,876
2015-04-15Grant / award644$23.2733,876
2015-01-15Grant / award496$25.1833,232
2015-01-12Grant / award (derivative)2,660—21,689
2014-10-15Grant / award595$20.9832,736
2014-07-15Grant / award522$23.9132,141
2014-04-15Grant / award522$23.9331,619
2014-01-15Open-market buy429$20.3631,097
2014-01-02Grant / award (derivative)3,369—19,029
2013-10-15Open-market buy440$19.9830,668
2013-08-15Open-market buy2,600$20.0230,228
2013-08-15Open-market buy2,400$20.0127,628
2013-07-15Open-market buy439$19.9325,228
2013-04-15Open-market buy408$21.4424,789
2013-01-15Grant / award481$18.1924,381
2013-01-03Grant / award (derivative)2,905—15,660
2012-10-15Open-market buy523$16.7123,900
2012-07-13Open-market buy596$14.6723,377
2012-04-13Open-market buy637$13.7322,781
2012-01-13Grant / award753$11.6122,144
2012-01-03Grant / award (derivative)4,476—12,755
2011-10-26Open-market buy4,000$25.004,000
2011-10-14Grant / award838$10.4321,391
2011-08-18Open-market buy15,000$10.4515,553
2011-07-15Grant / award553$12.50553
2011-04-20Grant / award (derivative)8,279—8,279
2011-04-15———0
2011-04-15Open-market buy5,000$13.0020,553

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.